| Perspective Therapeutics to Participate in Upcoming Investor Conferences in November | 10/29 07:00 | globenewswire.com |
| Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine | 10/23 07:00 | globenewswire.com |
| Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey | 10/16 07:00 | globenewswire.com |
| Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma Research | 10/11 08:30 | globenewswire.com |
| Perspective Therapeutics to Present at the 21st International Congress of the Society for Melanoma Research | 10/10 17:14 | globenewswire.com |
| Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma Day | 10/07 07:00 | globenewswire.com |
| Perspective: VMT01/02 Melanoma Data Coming For Radiotherapeutic Proof-Of-Concept | 10/02 15:11 | seekingalpha.com |
| Perspective Therapeutics Inc (CATX) Trading 3.4% Higher on Oct 2 | 10/02 12:10 | gurufocus.com |
| Perspective Therapeutics to Present at the 37th Annual Congress of the European Association of Nuclear Medicine | 09/30 07:00 | globenewswire.com |
| Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive Melanoma | 09/05 07:00 | globenewswire.com |